marketing-medtech

**Source:** GetYourJob (classified health-software, actively hiring developers)
**Founder:** Victoire Bach — Co-founder & Directrice Générale / Co-CEO
**Background:** tech | verified: True — Tech / engineering. Victoire Bach is an engineer ("ingénieure"), graduate of CentraleSupélec specializing in artificial intelligence, with an additional ESCP Business School degree in strategy/consulting. She co-founded Hopia (AI for hospital resource/scheduling optimization), which originated from a CentraleSupélec entrepreneurship hackathon. She is Co-founder & Directrice Générale/CEO.
**Stage / fundraise:** Seed-stage healthtech, founded 2020, ~19 employees (early 2025) planning to roughly double headcount by year-end; 1,700+ users across 20+ institutions. / Raised EUR 3.5M seed announced 28 Jan 2025, co-led by Iris Capital and Kurma Partners with healthtech/tech business angels.
**Regulatory trigger:** Likely NOT a regulated SaMD. Hopia is hospital workforce/resource scheduling and care-pathway planning software (administrative/operational optimization), not diagnostic or therapeutic software. No MDR / IEC 62304 / CE class is claimed in any source reviewed. The compliance angle (SOUP register, MDR/62304 traceability) therefore does not clearly apply to the core product, which is the main reason this lead is below ICP fit. "Hopia Parcours" (care-pathway optimization) is worth monitoring but is not positioned as a medical device.
**Email:** contact@hopia.eu (confidence medium) — contact@hopia.eu is published on Hopia's legal mentions page (https://hopia.eu/fr/mentions-legales). This is the generic company inbox, not Victoire Bach's personal address. A personal-address pattern (victoire.bach@hopia.eu) appears only on a third-party email-aggregator and is NOT a confirmed/published address, so it is not asserted here.
**LinkedIn:** https://www.linkedin.com/in/victoire-bach/ **Website:** https://hopia.eu
**Score:** 6 -> Tier C
**Hook:** Hopia is doubling its engineering team post-seed to scale planning AI plus the new Hopia Parcours care-pathway product. Because the founders are CentraleSupelec AI engineers with strong internal tech DNA, the OmDev pitch is augmentation rather than replacement: a senior, dedicated team + CTO at a fixed monthly price (~3x cheaper than hiring those same engineers in-house) to absorb scaling work and let the founding engineers stay on the algorithmic core. If Hopia Parcours ever crosses into regulated SaMD territory (MDR/IEC 62304), OmDev's built-in compliance engine (signed SOUP register + requirements-to-code-to-test traceability) becomes a differentiator. Note: weaker ICP fit because the core scheduling product is operational software, not a regulated medical device.

---

## Founder & background
Victoire Bach is co-founder and Directrice Generale (Co-CEO) of Hopia, named director of publication on the company's legal mentions page ([hopia.eu](https://hopia.eu/fr/mentions-legales)). She graduated from CentraleSupelec in artificial intelligence and ESCP Business School in strategy & consulting ([Yunova](https://yunovaconsulting.com/victoire-vach-co-fondatrice-de-hopia-lia-au-service-de-la-sante/)). She co-founded Hopia in 2020 with Matthias Lesage, also a CentraleSupelec engineer. Background = **tech/AI engineer** (not finance/insurance), which is below OmDev's preferred founder profile.

## Funding & momentum
Hopia raised **EUR 3.5M seed on 28 Jan 2025**, co-led by Iris Capital and Kurma Partners with healthtech/tech angels ([Iris](https://www.iris.vc/articles/hopia-raises-eu3-5-million-to-free-up-caregivers-time-and-improve-patient-pathways-with-ai), [Frenchweb](https://www.frenchweb.fr/hopia-leve-35-millions-deuros-pour-reinventer-lefficience-des-etablissements-medicaux-grace-a-lia/450981)). Traction: 1,700+ users across 20+ institutions (CHU de Brest, Vivalto Sante, Elsan, Saint-Joseph). Team ~19, planning to roughly double headcount by year-end including technical engineers.

## Product & regulatory
Hopia builds AI scheduling/planning software for hospitals — explainable constrained-optimization that replaces Excel and generates equitable staff schedules, plus "Hopia Parcours" for care-pathway planning ([Iris](https://www.iris.vc/articles/hopia-raises-eu3-5-million-to-free-up-caregivers-time-and-improve-patient-pathways-with-ai)). **This is operational/admin software, not a diagnostic/therapeutic SaMD.** No MDR / IEC 62304 / CE class is claimed in any reviewed source, so OmDev's compliance engine has no clear current trigger — the main reason for the low tier.

## Pain & buying signals
**Actively hiring developers (GetYourJob signal)**, consistent with the public post-seed plan to roughly double the team and recruit technical/operational engineers ([Iris](https://www.iris.vc/articles/hopia-raises-eu3-5-million-to-free-up-caregivers-time-and-improve-patient-pathways-with-ai)). However both founders are AI engineers, so there is strong in-house dev DNA (reduces the "thin team" fit). No QARA/regulatory-affairs hire, agency dependence, audit, or deadline signal surfaced.

**Why OmDev fits:** Best framed as augmentation, not replacement — a dedicated senior team + CTO at a fixed monthly price (~3x cheaper than hiring those same engineers in-house) to absorb scaling/product work while the founding engineers keep the algorithmic core. If Hopia Parcours moves into regulated SaMD territory, OmDev's signed SOUP register and requirements-to-code-to-test traceability become a differentiator. Caveat: weak ICP fit today (tech founder, operational non-regulated product, internal eng capacity) — Tier C, monitor for a regulatory pivot.

---
**Sources:** https://yunovaconsulting.com/victoire-vach-co-fondatrice-de-hopia-lia-au-service-de-la-sante/ · https://www.iris.vc/articles/hopia-raises-eu3-5-million-to-free-up-caregivers-time-and-improve-patient-pathways-with-ai · https://www.frenchweb.fr/hopia-leve-35-millions-deuros-pour-reinventer-lefficience-des-etablissements-medicaux-grace-a-lia/450981 · https://hopia.eu/fr/mentions-legales · https://oeil-esante.media/focus-startup/hopia-lia-qui-reinvente-les-plannings-et-lefficience-des-hopitaux/ · https://www.linkedin.com/in/victoire-bach/